Effect of serum dialysate calcium gradient. Multivariable extended Cox regression models accounting for non-proportional hazard (where required). Data are expressed as HR with 95% CI. Model 3: fully adjusted model, country as random effect plus adjustment for age, sex, ethnicity, comorbidities (diabetes, cardiovascular disease, liver disease, and cancer), vascular access, treatment time, Kt/V, ultrafiltration volume per session, blood hemoglobin, serum albumin, calcium-containing phosphate binders, active vitamin D and analogs, and calcimimetic agents. Model 4: model 3 plus dialysate bicarbonate.
. | All-cause mortality . | Cardiovascular mortality . | Sudden cardiac death . | |||
---|---|---|---|---|---|---|
SCa—DCa (per 1mEq/l increase) . | HR (95% CI) . | P value . | HR (95% CI) . | P value . | HR (95% CI) . | P value . |
Model 3 | 1.16 (1.09–1.24) | <.001 | 1.23 (1.12–1.35) | <.001 | 1.69 (1.41–2.03) | <.001 |
. | All-cause mortality . | Cardiovascular mortality . | Sudden cardiac death . | |||
---|---|---|---|---|---|---|
SCa—DCa (per 1mEq/l increase) . | HR (95% CI) . | P value . | HR (95% CI) . | P value . | HR (95% CI) . | P value . |
Model 3 | 1.16 (1.09–1.24) | <.001 | 1.23 (1.12–1.35) | <.001 | 1.69 (1.41–2.03) | <.001 |
Effect of serum dialysate calcium gradient. Multivariable extended Cox regression models accounting for non-proportional hazard (where required). Data are expressed as HR with 95% CI. Model 3: fully adjusted model, country as random effect plus adjustment for age, sex, ethnicity, comorbidities (diabetes, cardiovascular disease, liver disease, and cancer), vascular access, treatment time, Kt/V, ultrafiltration volume per session, blood hemoglobin, serum albumin, calcium-containing phosphate binders, active vitamin D and analogs, and calcimimetic agents. Model 4: model 3 plus dialysate bicarbonate.
. | All-cause mortality . | Cardiovascular mortality . | Sudden cardiac death . | |||
---|---|---|---|---|---|---|
SCa—DCa (per 1mEq/l increase) . | HR (95% CI) . | P value . | HR (95% CI) . | P value . | HR (95% CI) . | P value . |
Model 3 | 1.16 (1.09–1.24) | <.001 | 1.23 (1.12–1.35) | <.001 | 1.69 (1.41–2.03) | <.001 |
. | All-cause mortality . | Cardiovascular mortality . | Sudden cardiac death . | |||
---|---|---|---|---|---|---|
SCa—DCa (per 1mEq/l increase) . | HR (95% CI) . | P value . | HR (95% CI) . | P value . | HR (95% CI) . | P value . |
Model 3 | 1.16 (1.09–1.24) | <.001 | 1.23 (1.12–1.35) | <.001 | 1.69 (1.41–2.03) | <.001 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.